Finance

Lists
002907:SHE
Chongqing Pharscin Pharmaceutical Co Ltd
CNÂ¥14.64
+3.03%
(+0.43) 1D
Sep 8, 3:04:21 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002907...
Open
CNÂ¥14.15
High
CNÂ¥14.65
Low
CNÂ¥14.10
Mkt. cap
6.05B
Avg. vol.
15.38M
Volume
11.59M
Dividend
0.51%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 4, 2026
P/E ratio
106.29
52-wk high
CNÂ¥18.47
52-wk low
CNÂ¥11.42
EPS
CNÂ¥0.14
Shares outstanding
417.60M
No. of employees
1K
Open
CNÂ¥14.15
High
CNÂ¥14.65
Low
CNÂ¥14.10
Mkt. cap
6.05B
Avg. vol.
15.38M
Volume
11.59M
Dividend
0.51%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 4, 2026
P/E ratio
106.29
52-wk high
CNÂ¥18.47
52-wk low
CNÂ¥11.42
EPS
CNÂ¥0.14
Shares outstanding
417.60M
No. of employees
1K
About Chongqing Pharscin Pharmaceutical Co Ltd
CEO-
Employees1.44K
FoundedNov 4, 1996
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
184.00M
201.23M
211.85M
201.70M
Cost of goods sold
78.94M
92.46M
84.88M
84.18M
Cost of revenue
78.94M
92.46M
84.88M
84.18M
Research and development expenses
22.20M
30.52M
19.49M
13.73M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69.57M
82.65M
73.76M
70.71M
Operating expense
92.39M
117.57M
96.54M
90.78M
Total operating expenses
171.34M
210.02M
181.41M
174.96M
Operating income
12.66M
-8.79M
30.43M
26.74M
Other non operating income
-15.95M
15.80M
674.52K
-711.55K
EBT including unusual items
27.42M
-12.09M
37.60M
30.20M
EBT excluding unusual items
-1.67M
-1.01M
34.28M
27.44M
Income tax expense
11.79M
618.10K
8.69M
3.15M
Effective tax rate
43.00%
-5.11%
23.12%
10.43%
Other operating expenses
906.92K
5.32M
1.93M
4.13M
Net income
18.51M
-7.37M
32.79M
30.19M
Net profit margin
10.06%
-3.66%
15.48%
14.97%
Earnings per share
-
-
-
-
Interest and investment income
1.85M
150.51K
3.24M
1.71M
Interest expense
-238.82K
-8.19M
-70.53K
-292.83K
Net interest expenses
1.61M
-8.03M
3.17M
1.41M
Depreciation and amortization charges
-
-
-
-
EBITDA
33.92M
12.63M
51.86M
50.50M
Gain or loss from assets sale
-
-10.25M
-
-
AI content may include mistakes. Learn more
Google apps